Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK

BMJ Open

Volumn 6, Issue 6, 2016, Pages

  Taylor, Sylvia ^a   Taylor, Robert J ^b   Lustig, Roger L ^b   Schuck Paim, Cynthia ^b   Haguinet, François ^a   Webb, David J ^c   Logie, John ^c   Matias, Gonçalo ^a   Fleming, Douglas M ^d  

^a GSK   (Belgium)

^b SAGE Analytica LLC   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Children; Mortality; Otitis Media; Respiratory syncytial virus

Indexed keywords

MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; BRONCHIOLITIS; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DEATH; DISEASE SURVEILLANCE; GENERAL PRACTITIONER; HUMAN; ICD-10; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; NEWBORN; OTITIS MEDIA; OUTCOME ASSESSMENT; PRESCRIPTION; READ CODE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; TIME SERIES ANALYSIS; UNITED KINGDOM; URINARY TRACT INFECTION; AGE DISTRIBUTION; COST OF ILLNESS; FACTUAL DATABASE; FEMALE; HOSPITALIZATION; INCIDENCE; MALE; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SEASON; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; OTITIS MEDIA; PRIMARY HEALTH CARE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASONS; UNITED KINGDOM;

EID: 84974661294     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009337     Document Type: Article

References (25)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-28.
2. Fleming DM, Elliot AJ. Lessons from 40 years surveillance of influenza in England and Wales. Epidemiol Infect 2008; 136: 866-75.
3. Fleming DM, Pannell RS, Elliot AJ, et al. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child 2005; 90: 741-6.
4. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-Analysis. Lancet 2010; 375: 1545-55.
5. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003; 88: 1065-9.
6. Pitman RJ, Melegaro A, Gelb D, et al. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 2007; 54: 530-8.
7. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-86.
8. Simonsen L, Taylor RJ, Young-Xu Y, et al. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011; 2: e00309-10.
9. Williams T, van Staa T, Puri S, et al. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012; 3: 89-99.
10. Brock A, Griffiths C, Rooney C. The impact of introducing ICD-10 on analysis of respiratory mortality trends in England and Wales. Health Stat Q 2006; 29: 9-17.
11. ONS. Taxonomy. Office for National Statistics, 2010. http://www.ons. gov.uk/ons/taxonomy/index.html?nscl=Population+Estimates (accessed 17 Dec 2013
12. Patel JA, Nguyen DT, Revai K, et al. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine 2007; 25: 1683-9.
13. Nokso-Koivisto J, Räty R, Blomqvist S, et al. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol 2004; 72: 241-8.
14. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999; 340: 260-4.
15. Debiaggi M, Canducci F, Ceresola ER, et al. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J 2012; 9: 247.
16. Department of Health. Joint Committee on Vaccination and Immunisation. JCVI statements, advice and recommendations. http://.webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh. gov.uk/ab/JCVI/DH-094744 (accessed 23 Apr 2015
17. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54: 1427-36.
18. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005; 59: 586-90.
19. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza Other Respir Viruses 2013; 7: 35-45.
20. Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 2010; 21: 383-8.
21. Paget WJ, Balderston C, Casas I, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr 2010; 169: 997-1008.
22. Stockman LJ, Curns AT, Anderson LJ, et al. Respiratory syncytial virus-Associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012; 31: 5-9.
23. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-98.
24. Forster J, Ihorst G, Rieger CH, et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr 2004; 163: 709-16.
25. Fleming DM, Taylor R, Lustig R, et al. The burden of respiratory syncytial virus (RSV) infection in adults and the elderly in the United Kingdom. RSV Vaccines for the World. Porto; Portugal: 14-16 October 2013.